This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Evotec Nominates Dieter Weinand Chairman
Business board nomination

Evotec Nominates Dieter Weinand Chairman

Analysis based on 9 articles · First reported Apr 07, 2026 · Last updated Apr 07, 2026

Sentiment
20
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The nomination of Dieter Weinand as Chairman of Evotec's Supervisory Board is viewed positively, as his extensive experience is expected to enhance Evotec's commercial execution and strategic partnerships. This could lead to increased investor confidence and potential long-term value creation for Evotec.

Biotechnology Pharmaceuticals
Event Summary

Evotec has announced the nomination of Dieter Weinand as the new Chairman of its Supervisory Board, with the election proposed for the Annual General Meeting on June 11, 2026. Weinand, an industry veteran with over 30 years of experience, is expected to succeed Iris Löw-Friedrich, whose term concludes at the end of the 2026 Annual General Meeting. This strategic move aims to strengthen Evotec's leadership, focusing on commercial execution, strategic partnerships, and profitability as the company undergoes a transformation. Weinand's background includes leadership roles at Bayer, Pfizer, Bristol Myers Squibb, and Sanofi, and he currently serves on the boards of Replimune Group and Coya Therapeutics. He will reduce his current board commitments to dedicate sufficient time to his new role at Evotec.

Entities Involved
stock
Evotec
Evotec has nominated Dieter Weinand as the new Chairman of its Supervisory Board, aiming to strengthen commercial execution, strategic partnerships, and profitability. This move is part of Evotec's transformation into a more efficient and focused company.
Importance 100.0 Sentiment 20.0
per
Dieter Weinand
Dieter Weinand has been nominated as the Chairman of the Supervisory Board for Evotec. His extensive experience in the pharmaceutical industry is expected to support Evotec's strategic priorities and strengthen its relationships with customers and partners.
Importance 90.0 Sentiment 20.0
per
Iris Löw-Friedrich
Iris Löw-Friedrich's term as Chairwoman of the Supervisory Board of Evotec will conclude, with Dieter Weinand proposed as her successor.
Importance 30.0 Sentiment 0.0
per
Christian Wojczewski
Christian Wojczewski, CEO of Evotec, expressed gratitude to Iris Löw-Friedrich and welcomed Dieter Weinand's nomination, highlighting his expected contributions to Evotec's transformation.
Importance 10.0 Sentiment 0.0
stock
Coya Therapeutics
Dieter Weinand currently serves on the board of Coya Therapeutics, and will reduce his board seats to focus on his role at Evotec.
Importance 5.0 Sentiment 0.0
stock
Bristol Myers Squibb
Dieter Weinand has led business operations for companies including Bristol Myers Squibb.
Importance 5.0 Sentiment 0.0
stock
Replimune Group
Dieter Weinand currently serves on the board of Replimune Group, and will reduce his board seats to focus on his role at Evotec.
Importance 5.0 Sentiment 0.0
stock
Pfizer
Dieter Weinand has led business operations for companies including Pfizer.
Importance 5.0 Sentiment 0.0
stock
Sanofi
Dieter Weinand has led business operations for companies including Sanofi.
Importance 5.0 Sentiment 0.0
stock
Bayer
Importance 0.0 Sentiment 0.0
Relationships
Evotec related ↔ Christian Wojczewski
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.